Show Menu

A fully integrated developer and manufacturer of ovine polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for January 2015

Ovine antibodies to treat Ebola Virus Disease

MicroPharm Limited is pleased to announce that, following promising in vitro results, its ovine polyclonal antibody against Ebola has advanced to the in vivo evaluation stage of a Wellcome Trust-funded project for rapid down-selection of experimental Ebola therapies. These antibodies are being developed in collaboration with Public Health England (PHE) and the University of Oxford.

Read the full story

Posted on: Wednesday, 14th January 2015